107 related articles for article (PubMed ID: 3543397)
21. Pharmacokinetics of mecillinam after a single intravenous dose in patients with impaired renal function.
Moukhtar I; Nawishy S; Sabbour M
Int J Clin Pharmacol Res; 1987; 7(1):59-62. PubMed ID: 3583488
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of mecillinam against anaerobic bacteria.
Steinkraus GE; McCarthy LR
Antimicrob Agents Chemother; 1980 Jun; 17(6):954-6. PubMed ID: 6250471
[TBL] [Abstract][Full Text] [Related]
23. [In-vitro activity of mecillinam against urine isolates of Escherichia coli from outpatient departments in Germany].
Kresken M; Körber-Irrgang B; Naber KG
Aktuelle Urol; 2017 May; 48(3):243-247. PubMed ID: 28427111
[TBL] [Abstract][Full Text] [Related]
24. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations and penetration into prostate of mecillinam and ampicillin.
Jeppesen N; Frimodt-Møller C
Curr Med Res Opin; 1984; 9(3):213-8. PubMed ID: 6499514
[TBL] [Abstract][Full Text] [Related]
26. Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.
Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
Scand J Infect Dis; 1986; 18(5):439-45. PubMed ID: 3535050
[TBL] [Abstract][Full Text] [Related]
27. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
Dabernat H; Delmas C; Lareng MB
Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of amdinocillin in healthy adults.
Meyers BR; Jacobson J; Masci J; Srulevitch E; Hirschman SZ
Antimicrob Agents Chemother; 1983 Jun; 23(6):827-30. PubMed ID: 6311087
[TBL] [Abstract][Full Text] [Related]
29. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
Infection; 1980; 8(1):37-40. PubMed ID: 6246006
[TBL] [Abstract][Full Text] [Related]
30. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
Hanberger H; Nilsson LE; Svensson E; Maller R
J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
[TBL] [Abstract][Full Text] [Related]
31. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
[TBL] [Abstract][Full Text] [Related]
33. High-level resistance to mecillinam produced by inactivation of soluble lytic transglycosylase in Salmonella enterica serovar Typhimurium.
Costa CS; Antón DN
FEMS Microbiol Lett; 2006 Mar; 256(2):311-7. PubMed ID: 16499622
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
Mengelers MJ; van Klingeren B; van Miert AS
Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance.
Salmon SA; Watts JL; Yancey RJ
J Vet Diagn Invest; 1996 Jul; 8(3):332-6. PubMed ID: 8844576
[TBL] [Abstract][Full Text] [Related]
36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1989 Oct; 42(10):2141-73. PubMed ID: 2691714
[TBL] [Abstract][Full Text] [Related]
37. Comparison of in vitro and in vivo ampicillin susceptibility of Escherichia coli pretreated with low concentrations of mecillinam and ampicillin.
van der Voet GB; Mattie H; van Furth R
Scand J Infect Dis; 1983; 15(1):97-101. PubMed ID: 6302833
[TBL] [Abstract][Full Text] [Related]
38. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetic characterization of norfloxacin nicotinate in swine following systemic administration.
Shem-Tov M; Ziv G
Zentralbl Veterinarmed B; 1994 Mar; 41(1):60-70. PubMed ID: 7941848
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to mecillinam and other antibiotics and serogroups of enterotoxigenic Escherichia coli from children in Addis Ababa.
Stintzing G; Jacobsen J
J Antimicrob Chemother; 1983 Nov; 12(5):469-74. PubMed ID: 6323370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
